Physician profile
Andrea D Capps
NPI 1740365428
$716.54
in general payments reported to CMS, 2019-2025
9 companies · $16.83 in 2025
The $16.83 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.46 · 2020: $94.25 · 2021: $270 · 2022: $125 · 2023: $141 · 2025: $16.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $206.43 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.10 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Dompe US, INC. | $125.00 | 2023 | Oxervate |
| Abb Con-Cise Optical Group LLC | $42.42 | 2019 | |
| Glaukos Corporation | $30.21 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.83 | 2025 | Austedo Xr |
| Bausch & Lomb Americas INC. | $16.15 | 2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Capps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.